Lee Ainslie - Maverick Capital
Holding/activity history for Collegium Pharmaceutical, Inc. (COLL)
← All COLL superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q3 | 0 | 0.00 | Sell 100.00% | 0.02 | $31.26–39.58 · VW $37.06i | SEC | |
| 2024 Q2 | 39,596 | 0.02 | Add 346.25% | 0.02 | $30.42–40.49 · VW $34.19i | $1,274,991 | SEC |
| 2024 Q1 | 8,873 | <0.01 | Buy | <0.01 | $30.72–40.95 · VW $35.68i | $344,450 | SEC |
| 2023 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | $20.83–25.49 · VW $22.98i | SEC | |
| 2023 Q2 | 10,401 | <0.01 | Reduce 7.92% | <0.01 | $20.93–24.17 · VW $22.59i | $223,517 | SEC |
| 2023 Q1 | 11,296 | 0.01 | Add 5.17% | <0.01 | $22.67–30.22 · VW $26.58i | $270,991 | SEC |
| 2022 Q4 | 10,741 | <0.01 | Reduce 27.09% | <0.01 | $15.92–24.36 · VW $20.56i | $249,191 | SEC |
| 2022 Q3 | 14,732 | 0.01 | Buy | 0.01 | $15.40–20.27 · VW $17.51i | $236,000 | SEC |
| 2021 Q3 | 0 | 0.00 | Sell 100.00% | 0.01 | $17.67–25.63 · VW $21.56i | SEC | |
| 2021 Q2 | 33,751 | 0.01 | Buy | 0.01 | $21.27–25.66 · VW $23.39i | $798,000 | SEC |
| 2021 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | $18.76–26.91 · VW $23.82i | SEC | |
| 2020 Q4 | 6,926 | <0.01 | Buy | <0.01 | $17.24–22.52 · VW $19.34i | $139,000 | SEC |
| 2019 Q2 | 0 | 0.00 | Sell 100.00% | 0.08 | $10.55–17.02 · VW $13.24i | SEC | |
| 2019 Q1 | 395,080 | 0.08 | Buy | 0.08 | $13.10–18.88 · VW $16.25i | $5,982,000 | SEC |
| 2018 Q4 | 0 | 0.00 | Sell 100.00% | 0.08 | $13.70–19.83 · VW $17.03i | SEC | |
| 2018 Q3 | 421,993 | 0.08 | Reduce 0.61% | <0.01 | $14.00–24.44 · VW $18.24i | $6,220,000 | SEC |
| 2018 Q2 | 424,590 | 0.12 | Buy | 0.12 | $20.81–28.91 · VW $24.13i | $10,126,000 | SEC |
Price snapshot:
Current price$34.82
52-week low$29.19
52-week high$50.79